LBCTR2020033434已完成3 期
AN OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB IN PATIENTS WITH EARLY STAGE RELAPSING REMITTING MULTIPLE SCLEROSIS - Ensemble
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 至 99（—）
- 性别
- All
入选标准
- •Participant has histologically confirmed locally advanced/metastatic (stage IIIB/IIIC or IV)
- •- Participant has a KRAS G12C mutation present in tumor tissue prior to enrollment, as determined by a Novartis designated central laboratory.
- •- Participants has received one prior platinum-based chemotherapy regimen and one prior immune checkpoint inhibitor therapy for locally advanced or metastatic disease
- •- Participant has at least 1 evaluable (measurable or non-measurable) lesion by RECIST 1.1 at the screening visit.
排除标准
- •- Participant has previously received docetaxel, KRAS G12C inhibitor or any other systemic therapy for their locally advanced or metastatic NSCLC other than one platinum-based chemotherapy and one prior immune check point inhibitor
- •- Participant has EGFR-sensitizing mutation and/or ALK rearrangement by local laboratory testing
- •- Participant has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
- •- Participant has an history of interstitial lung disease or pneumonitis grade > 1.
研究者
相似试验
已完成
3 期
To Evaluate the Effect of Padabhyanga with Ksheerabala Taila in Insomnia among Breast Cancer SurvivorsCTRI/2021/12/038531Dr Veena22
尚未招募
3 期
To Evaluate the Effect of Pratimarsa Nasya with Ksheerabala Thaila 101 in Digital Eye Strain among College Students.CTRI/2022/07/044496Dr Reshma Mohan
进行中（未招募）
1 期
A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 4, 5, or 6 InfectioChronic Hepatitis C Virus Genotype 4, 5 or 6 InfectionMedDRA version: 18.0Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-002349-80-ESAbbVie Deutschland GmbH & Co. KG120
进行中（未招募）
1 期
A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 4, 5, or 6 InfectioEUCTR2015-002349-80-PTAbbVie Deutschland GmbH & Co. KG130
进行中（未招募）
1 期
A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 4, 5, or 6 InfectioEUCTR2015-002349-80-GBAbbVie Deutschland GmbH & Co. KG121